Price Alert

SELLAS Life Sciences Grou... (SLS)

NASDAQ: SLS · Real-Time Price · USD

1.74

0.11 (6.75%)

At close: Aug 18, 2025, 3:59 PM

1.75

0.56%

Pre-market: Aug 19, 2025, 08:29 AM EDT

6.75% (1D)

Bid	1.73
Market Cap	183.22M
Revenue (ttm)	n/a
Net Income (ttm)	-27.13M
EPS (ttm)	-0.3
PE Ratio (ttm)	-5.8
Forward PE	-4.16
Analyst	Strong Buy

Ask	1.76
Volume	2,559,744
Avg. Volume (20D)	2,854,062
Open	1.63
Previous Close	1.63
Day's Range	1.61 - 1.77
52-Week Range	0.77 - 2.27
Beta	2.27

About SLS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol SLS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

News

2 weeks ago · zacks.com

SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)

SELLAS Life Sciences Group (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago · zacks.com

Galena Biopharma (SLS) Upgraded to Buy: What Does It Mean for the Stock?

Galena Biopharma (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.